https://www.zacks.com/stock/news/2240665/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2240665
Mar 14, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:3241475086781664115
0
https://www.zacks.com/stock/news/2235447/boston-scientific-bsx-grows-ic-business-with-new-fda-nod?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2235447
Mar 04, 2024 - The AGENT DCB of Boston Scientific (BSX) is already available in Europe, parts of Asia Pacific and Latin America.
zc:-2539295009716458744
0
https://www.zacks.com/stock/news/2234656/why-boston-scientific-bsx-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2234656
Mar 01, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zc:-1835752904873817091
0
https://www.zacks.com/stock/news/2223513/here-s-why-you-should-invest-in-boston-scientific-bsx-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2223513
Feb 08, 2024 - Investors are optimistic about Boston Scientific (BSX) on strength across the target market and upbeat guidance.
zc:9186958691286889034
0
https://www.zacks.com/commentary/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup?cid=CS-ZC-FT-research_daily-2220146
Feb 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C).
zc:-1303935316860058389
0
https://www.zacks.com/stock/news/2220412/pbh-vs-bsx-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2220412
Feb 02, 2024 - PBH vs. BSX: Which Stock Is the Better Value Option?
zc:-8379868979740707708
0
https://www.zacks.com/stock/news/2218857/boston-scientific-bsx-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2218857
Jan 31, 2024 - The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:2996653865207438020
0
https://www.zacks.com/commentary/2212742/top-research-reports-for-microsoft-procter-gamble-astrazeneca?cid=CS-ZC-FT-research_daily-2212742
Jan 19, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), The Procter & Gamble Company (PG) and AstraZeneca PLC (AZN).
zc:8123009532531147682
0
https://www.zacks.com/stock/news/2211577/pbh-or-bsx-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2211577
Jan 17, 2024 - PBH vs. BSX: Which Stock Is the Better Value Option?
zc:6526733881755184535
0
https://www.zacks.com/stock/news/2211533/what-s-in-store-for-boston-scientific-bsx-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2211533
Jan 17, 2024 - Boston Scientific (BSX) is expected to have witnessed strong growth of the WATCHMAN franchise in the fourth quarter, given the FDA approval of WATCHMAN FLX Pro in September.
zc:-164476386339662944
0